Parathyroid hypertensive factor
CA 2030516 C · Owner: Kaneko, Toyoji · Inventors: Kaneko, Toyoji; Pang, Peter K.T.; Lewanczuk, Richard Z.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A new circulating factor from the parathyroid gland of some hypertensive mammals has been isolated and characterized. Polyclonal and monoclonal antibodies raised against this factor are usable as a screen for the presence of the factor. The factor is involved in the control of calcium uptake in cells. Hypertensive mammals may be treated to lower mean blood pressure by administering a calcium channel blocking agent together with one or both of a calcium supplement and Vitamin D. The hypotensive effect of this combination is synergistic and the dose response is more predictable than the administration of any of these agents singly.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 22, 1990 and granted October 10, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 22, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 22, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.